The deal gives the instruments specialist a portfolio of cloud-based applications to increase productivity
Bruker Corporation has acquired Arxspan, a provider of cloud-based scientific software and workflow solutions, based in Southborough, Massachusetts, in the US.
Arxspan is known for its line of cloud-based products for the management of research data under the Arxlab brand. The company has a focus on serving pharmaceutical and biopharma customers. Financial details of the transaction have not been disclosed.
The acquisition gives Bruker access to a range of software tools for customers in the chemistry, pharmaceutical, biopharma and analytical laboratory markets.
The deal complements the Mestrelab strategic partnership allowing Bruker to offer state-of-the-art chemistry and biopharma software tools, supporting discovery and development.
Commenting on the acquisition, Dr Falko Busse, Group President for Bruker Biospin, said: "Bruker is committed to providing intuitive end-to-end solutions that make analysis and knowledge extraction in scientific research faster and easier. Our new software solutions enable our biopharma customers to increase their productivity in drug discovery and development.
Arxspan was founded in 2011 to deliver cloud-based scientific informatics tools to customers around the globe. That year, Arxspan's multi-tenant cloud Electronic Laboratory Notebook (ELN) was released to customers in the academia and biotech market place.
The ELN was launched with an enterprise-level feature set designed to support small biotech start-ups as well as global pharma. In 2013, Arxspan released the integrated Registration module in collaboration with multiple customers.
In 2017, Arxspan released the Workflow module to enable close coordination of compound/biologic request and fulfilment between companies and their external collaborators.
Peter Rosati, the CEO and a co-founder of Arxspan, commented: "The merger with Bruker will increase our footprint and help us support and grow our increasingly global customer base.
Rosati said the company is focused on showing immediate benefits of the merger to its pharma and biopharma customers. "Arxspan's proven enterprise SaaS platform will be a solid foundation for Bruker's chemistry and biology informatics offerings," he enthused.